Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
Stock Information for Algernon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.